Igan Partners is a company that specializes in providing strategic consulting and implementation services for healthcare organizations, with a particular focus on telehealth solutions during the coronavirus crisis. They aim to help healthcare providers adapt to the evolving landscape of virtual care and digital health tools.

Igan Partners

iGan Arabia

Based in Toronto, we partner with exceptional founders focused on commercializing and scaling technological advancements in healthcare.

We provide portfolio companies with smart-capital, active support, and access to a network of industry partners and sector specific co-investors to help them grow and succeed.

We are a dedicated team of entrepreneurs, company builders, operators, and investors, bringing unique expertise and domain-specific knowledge to our investments.

Quandl

Adracare

Right Health

SceneDoc

BrainFx

MolecuLight

Think Research

Vemba

iGan Partners

iGan Partners is thrilled to announce the exit of our investment in portfolio company eSight through an acquisition by Gentex Corporation! 

eSight is a leading provider of vision enhancement technologies, providing assistive eyewear technology compatible with over 20 eye conditions to individuals with visual impairments. We’re excited to see eSight and Gentex’s strategic collaboration grow, and we’re confident in their ability to further develop and unlock new visual possibilities.

Read more: https://lnkd.in/gsyayQ4k

Metric
Company Name	Igan Partners
Symbol
MSH ID	COM:IGANPARTNERS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare & Health Services
Country	CA
Stage
Employee Count	26
Website	iganpartners.com
LinkedIn	igan-partners
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	90.47
28-Day Growth Score	17.75
90-Day Growth Score	21.09
365-Day Growth Score	15.65

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:IGANPARTNERS

Igan Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue